The global market for antiparasitic drugs is undergoing a seismic shift driven by the rising demand for animal protein, the "pet humanization" trend, and increasing awareness of zoonotic diseases. In the current commercial landscape, antiparasitic drugs are no longer just curative interventions; they are foundational elements of preventive healthcare systems in both livestock management and companion animal care. From the vast cattle stations in Australia to the intensive poultry farms in Southeast Asia, the need for reliable, high-purity parasiticides like Ivermectin and Toltrazuril has never been higher.
Industrial manufacturing of these drugs requires sophisticated chemical synthesis and strict adherence to GMP (Good Manufacturing Practices). As leading factories and suppliers, we recognize that the global supply chain is becoming more complex. Large-scale agricultural operations in the Americas and Europe are increasingly looking toward China for high-quality, cost-effective active pharmaceutical ingredients (APIs) and finished dosage forms to maintain their competitiveness. This demand is further bolstered by the expansion of the aquaculture sector, particularly in salmon farming, where specialized parasiticides are essential for maintaining yield and animal welfare.
Current industry trends are focusing on Long-Acting Formulations and Multimodal Solutions. Farmers and pet owners are seeking products that require fewer administrations but provide longer protection windows. For instance, our Toltrazuril Oral Solution is designed to combat Coccidiosis in poultry with maximum bio-availability, reducing the frequency of intervention and minimizing stress on the flock.
Technological advancements in precision medicine are also entering the veterinary space. AI-driven diagnostic tools now allow for more targeted use of antiparasitic drugs, ensuring that the right molecule is used at the right time to prevent the development of drug resistance—a major concern for the World Health Organization (WHO) and the OIE.
For international buyers—ranging from multi-national pharmaceutical giants to regional agricultural cooperatives—the primary concern is Quality Assurance and Regulatory Compliance. When sourcing custom antiparasitic drugs, procurement officers prioritize suppliers who can provide comprehensive dossiers, stability testing data, and certificate of analysis (COA) for every batch.
As a specialized supplier, we offer OEM and Custom Formulation services. This is particularly vital in markets like Africa and the Middle East, where local climate conditions require specific drug concentrations or unique delivery mechanisms (such as specialized pour-on liquids or weather-resistant oral solutions). The ability to provide "Private Label" services allows local distributors to build brand equity while relying on the manufacturing powerhouse of a Chinese GMP facility.
Localization is key to pharmaceutical success. In the pet care segment, convenience is king. Our Ivermectin + Clorsulon Injection exemplifies a high-efficacy treatment designed for large-scale livestock, covering everything from cattle and camels to sheep and goats. It effectively targets both internal and external parasites, which is crucial in tropical regions where tick-borne diseases and liver flukes are endemic.
Conversely, for the urban "pet parent," our Fipronil drops offer a low-toxicity, easy-to-apply solution for cats and dogs, reflecting the global shift toward companion animal wellness in high-income economies.
Hangzhou Jeci Biochem Technology Co., Ltd. is located in Hangzhou, Zhejiang Province. We are committed to sales of active pharmaceutical ingredients, pharmaceutical intermediates, nutritional products and food additives, cooperative R & D, custom manufacturing, sales and service as well as import of these kinds of materials.
In China, we have a strong collaborative R&D team, working in depth with new drug research institutes and multiple custom processing plants. We have very good domestic sales channels and have long-term relationships with domestic companies, including product applications, technology transfer, product supply, custom processing, and exclusive agents for multiple products in multiple regions. In addition, we also provide factory quality management system certification consulting services.
Internationally, we have long-term trade relations with India, Southeast Asia, South Korea, Japan and other markets, and provides products in the whole process of market and sales services. At the same time, we also provide product registration, consulting and sales channel expansion services for overseas companies in the Chinese market.
Our drugs and intermediates are widely used in critical industrial and medical applications. We serve as the backbone for manufacturers producing end-user pharmaceutical products across the globe.
We are able to assemble and produce larger quantities of intermediates and provide some advanced, convenient manufacturing capabilities, including batch processing and customization.
For the company's main product intermediates: We can maximize our advantages, meet the requirements of most customers and complete the task within the specified time limit. Our facility is equipped with state-of-the-art reactors, filtration systems, and analytical labs to ensure every gram of product meets our rigorous internal standards.
The competitive advantage of our Chinese factory lies in the synthesis of Quality, Scale, and Cost. China has developed a world-class infrastructure for chemical production, allowing us to source raw materials efficiently and pass those savings to our clients. However, cost is nothing without quality. By maintaining a deep collaborative R&D network with leading institutes, we stay ahead of the curve in pharmaceutical innovation.
Our strategic location in Hangzhou provides us with logistical access to one of the world's most efficient port networks, ensuring that our products—whether they are Florfenicol or Tylosin Tartrate—reach our international partners in South America, Southeast Asia, and Europe within optimal timeframes. We understand that in the pharmaceutical world, reliability is the greatest currency.